Echo Therapeutics, Inc.
(Other OTC/NBB : ECTE)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Like Small Cap Stocks < $20?
You should, we just banked a 30% winner in 2 days!
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
ABTAbbott Laboratories 0.17%106.840.8%$726.74m
TMOThermo Fisher Scientific, Inc. -0.89%429.071.0%$630.35m
MDTMedtronic Plc -0.19%107.610.6%$545.96m
ISRGIntuitive Surgical, Inc. -3.72%655.572.4%$439.60m
DHRDanaher Corp. -0.53%206.050.7%$411.85m
BDXBecton, Dickinson & Co. 1.80%231.901.0%$405.44m
INOInovio Pharmaceuticals, Inc. 8.49%17.005.9%$375.99m
QDELQuidel Corp. 10.87%189.317.7%$369.77m
DXCMDexCom, Inc. 0.80%389.317.9%$302.80m
SYKStryker Corp. -2.55%206.181.3%$277.61m
BSXBoston Scientific Corp. -2.98%38.491.0%$275.36m
VARVarian Medical Systems, Inc. -0.45%172.729.1%$271.99m
BAXBaxter International, Inc. 0.75%82.941.8%$251.90m
ALGNAlign Technology, Inc. -2.15%320.976.4%$227.10m
EWEdwards Lifesciences Corp. -0.56%83.220.4%$220.20m

Company Profile

Echo Therapeutics, Inc. is a medical device company, which engages in the development of non-invasive, and wireless continuous glucose monitoring system for use in the diabetes outpatient market. It offers needle-free skin preparation device as a platform technology that allows for enhanced skin permeation enabling extraction of analytes, such as glucose and delivery of topical pharmaceuticals. The company was founded on September 14, 2007 and is headquartered in Iselin, NJ.